Principles of medicamental therapy of patients with subarachnoidal hemorrhages owing to a rupture of arterial aneurysms of a brain
Keywords:
субарахноїдальний крововилив, артеріальна аневризма.Abstract
Clinico-functional peculiarities of subarachnoid haemorrhage due to cerebral aneurysm rupture was examined in connection with clinico-anatomical form of the disease, haemorrhage source location. The 300 patients were investigated, divided into 5 clinical groups according to computerised tomography characteristics of the haemorrhage. The analysis of disease course was performed with accenting on Hunt-Hess grading at admission, clinical picture at admission and dynamically. The principles of treatment tactic choice on the basis of clinico-anatomical form and stage of the pathology, were elaborated.References
Гусев С.A., Гусев А.С., Крылов В.В. Ультраструктурные изменения коллаген-эластического каркаса основной артерии в остром периоде разрыва аневризм // 2-й съезд нейрохирургов Российской Федерации. — СПб, 1998. — С.178—179.
Дзяк Л.А., Голик В.А. Опыт применения препарата Фраксипарин в терапии острых церебральных ишемий // Укр. мед. часопис.—1999. — Т.12.— №4. — С.76—80.
Закарявичюс Ж., Медведев Ю.А., Зубков Ю.Н. Патоморфологические аспекты констриктивно-стенотической артериопатии у больных в геморрагический период церебральных аневризм // 2-й съезд нейрохирургов Российской Федерации. — СПб, 1998. — С.180.
Закарявичюс Ж., Никифоров Б.М., Панунцев В.С. и др. Ангиографические особенности констриктивно-стенотической артериопатии у больных в геморрагическом периоде церебральных аневризм // 2-й съезд нейрохирургов Российской Федерации. — СПб, 1998. — С.181.
Зорін М.О., Дзяк Л.А., Голик В.А. Артеріальні аневризми головного мозку. - Дніпропетровськ: Пороги, 1998.—42 с.
Зубков Ю.Н., Панунцев В.С., Иванова Н.Е. и др. Тактика лечения больных с осложненным течением разрыва аневризм головного мозга // 2-й съезд нейрохирургов Российской Федерации. — СПб, 1998. — С.158.
Котрелл Д.Е. Защита мозга // Анестезиология и реаниматология.—1996. — №2. — С.81—85.
Кригер Д. Интенсивное неврологическое лечение тяжелых ишемических инсультов полушарий головного мозга // 4-й Междунар. Симпоз. по транскраниальной допплерографии и электрофизиологическому мониторингу. — СПб, 1997. — С.146.
Лебедев В.В., Крылов В.В., Холодов С.А., Шелковский В.Н. Хирургия аневризм головного мозга в остром периоде кровоизлияния . — М.: Медицина, 1996.—256 с.
Лубнин А.Ю., Шмигельский А.В., Сазонова О.Б. и др. Фармакологическая защита мозга во время операции у больных с гигантскими артериальными аневризмами церебральных сосудов // 4-й Междунар. Симпоз. по транскраниальной допплерографии и электрофизиологическому мониторингу. СПб, — 1997. — C.196—200.
Попов Г.Г., Крылов В.В., Яхно Н.Н. Гидроцефалия в остром периоде субарахноидального кровоизлияния // 2-й съезд нейрохирургов Российской Федерации. — СПб, 1998. — С.191.
Asada M., Kong J., Nakamura M. Thrombolytic therapy with tissue plasminogen activator for prevention of vasospasm in experimental subarachnoid hemorrhage: its efficacy and problems // Neurol. Res.—1996. — V.18, №4. — Р.342—344.
Barker F.G., Ogilvy C.S. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis // J. Neurosurg.—1996. — V.84, №3. — P.405—414.
Bayliss W.M. On the local reactions of the arterial wall to changes of internal pressure // J. Physiol.—1985. — V.28. — P.220—231.
Beretta L., Calvi M., Gemma M. Seizures associated with acute subarachnoid hemorrhage. Emergency diagnosis and treatment // Minerva Anestesiol.—1998. — V.64, №4. — Р.131—133.
Biestro A.A., Alberti RA., Soca A.E. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report // J. Neurosurg.—1995. — V.83, № 4. — P.627—630.
Carteri A., Billeci D., Copetti E. Prospective pharmacologic treatments for subarachnoid hemorrhage // Minerva Anestesiol.—1998. — V.64, №5. — P.257—259.
Doutremepuich C., Toulemonde F., Bousquet F. et al. // Thromb. Res.—1986. — V.43. — P.691—695.
Feigin V.L., Rinkel G.J., Algra A. et al. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review // Neurology.—1998. — V.50, №4. — P.876—883.
Findlay J.M. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society // Canad. J. Neurol. Sci.—1997. — V.24, №2. — Р.161—170.
Glick H.A., Polsky D., Willke R.J. et al. Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States // Stroke. — 1998.—V.29, №2. — P.351—358.
Glick H., Willke R., Polsky D. Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia // Intern. J. Technol. Assessm. in Health Care.—1998. — V.14, №1. — P.145—160.
Greenamyre J.T., Porter R. Anatomy and physiology of glutamat in the CNS // Neurology.—1994. — V.44, Suppl. 8. — P.7—13.
Gumprecht H., Winkler R., Gerstner W. Therapeutic management of grade IV aneurysm patients // Surg. Neurol.—1997. — V.47, №1. — P.54—59.
Haley E.C., Kassell N.F., Torner J.C. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study // J. Neurosurg.—1994. —V.80, №5. — P.788—796.
Hallenbeck J.M. Cytokines, macrophages and leucocytes in brain ischemia // Neurology.—1997. — V.49, Suppl.4. — P.5—9.
Hamann G., Haass A., Schimrigk K. Beta - blockade in acute aneurysmal subarachnoid haemorrhage // Acta Neurochir.—1993. — V.121, №3—4. — Р.119—122.
Hongo K., Kobayashi S. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage // Neurol. Res.—1993. — V.15, №4. — P.218—224.
Hunt W.E., Hess R.M. Surgical risk as relayed to time of intervention in the repair of intracranial aneurysms // J. Neurosurg.—1968. — V.28. — P.14—20.
Inagawa T. What are the actual incidence and mortality rates of subarachnoid hemorrhage? // Surg Neurol.—1997. — V.47, №1. — P.47—53.
Jagroop I.A., Barradas M.A., Mikhailidis D.P. A low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation // Brit J. Clin. Pharmacol.—1996. — V.41, №2. — P.163—165.
Kakarieka A., Schakel E.H., Fritze J. Clinical experiences with nimodipine in cerebral ischemia // J. Neur. Transmiss.—1994. — Suppl.43. — P.13—21.
Kawano T., Kazekawa K., Nakashima S. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study // Intern. J. Clin. Pharmacol. Ther.—1995. — V.33, №9. — P.513—517.
Kim C.J., Bassiouny M., Macdonald R.L. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys // Stroke.—1996. — V.27, №9. — Р.1629—1633.
King W.A., Martin N.A. Critical care of patients with subarachnoid hemorrhage // Neurosurg. Clin. N. Amer.—1994. — V.5, №4. — P.767—787.
Kurokawa Y., Uede T., Ishiguro M., Honda O. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm // Surg. Neurol.—1996. — V.46, №5. — Р.500—508.
Langelaar G., Leeuwenkamp O.R., Sterkman O.R. et al. The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhage // J. Intern. Med. Res.—1996. — V.24, №5. — Р.425—432.
Lee K.C., Huh S.K., Park H.S. Management of poorgrade patients with ruptured intracranial aneurysm // Keio J. Med.—1997. — V. 46, №2. — P.69—73.
Lombardi D., Gaetani P., Marzatico F. et al. Effect of high-dose methylprednisolone on anti-oxidant enzymes after experimental SAH // J. Neurol. Sci.—1992. — V.111, №1. — P.13—19.
Manavalan P., Richardson D., Rayford R. ECG and cardiac enzymes changes associated with subarachnoid hemorrhage // J. Arkansas Med. Soc.—1997. — V.93, №12. — Р.592—593.
Massei R., TaVola M., Mottura G. Subarachnoid hemorrhage: protective hypotension in delayed surgery // Minerva Anestesiol.—1998. — V.64, №5. — Р.209—210.
Mauray S., de Raucourt E., Talbot J.C. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan // Biochim. Biophys. Acta.—1998. — V.1387, №1—2. — P.84—94.
Mayberg M.R. Cerebral vasospasm // Neurosurg. Clin. N. Amer.—1998. — V.9, №3. — P.615—627.
Mayberg M.R., Batjer H.H., Dacey R. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association // Stroke.—1994. — V.25. — P.2315—2328.
Mayer S.A., Solomon R.A., Fink M.E. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage // Neurosurgery.—1998. — V.42, №4. — P.759—768.
Melon E., Rimaniol J.M. Pharmacological treatment of vasospasm in subarachnoid hemorrhage // Ann. Franc. Anesth. Reanim.—1996. — V.15, №3. — P.366—373.
Neau J.P., Ingrand P., Couderq C. et al. Recurrent intracerebral hemorrhage // Neurology.—1997. — V.49, №1. — P.106—113.
Nunnelee J.D. Low-molecular-weight heparin // J. Vasc. Nurs.—1997. — V.15, №3. — P.94—96.
Ohno K., Suzuki R., Masaoka H. A review of 102 consecutive patients with intracranial aneurysms in a community hospital in Japan // Acta Neurochir. (Wein).—1988. — V.94. — P.23—27.
Pagni C.A., Cossandi C., Fontanella M. et al. Pharmacologic therapy of subarachnoid hemorrhage // Minerva Anestesiol.—1998. — V.64, №5. — P.221—224.
Patel R.V., Kertland H.R., Jahns B.E. et al. Labetalol: response and safety in critically ill hemorrhagic stroke patients // Ann. Pharmacother.—1993 — V.27, №2. — Р.180—181.
Popovic E.A., Danks R.A., Siu K.H. Experience with nimodipine in aneurysmal subarachnoid haemorrhage // Med. J. Austral.—1993. — V.158, №2. — P.91—94.
Radhakrishnan D., Menon D.K. Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnoid haemorrhage: implications for monitoring // Anaesthesia.—1997. — V.52, №5. — P.489—491.
Roos E.M., Beenen L.F.M., Groen R.J.M. et al. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery // J. Neurol. Neurosurg. Psych.—1997. — V.63. — P.490—493.
Rosenberg R.D. Biochemistry and pharmacology of low molecular weight heparin // Seminars Hematol.—1997. — V.34. — P.2—8.
Rousseaux P., Gomis P., Bazin A. Comparison of 2 consecutive series of aneurysmal subarachnoid hemorrhage with or without nimodipine and study of the temperature curve /// Neuro-Chirurgie.—1993. — V.39, №3. — P.157—165.
Sabbatini M., Strocchi P., Amenta F. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders // Clin. Exper. Hypertens.—1995. — V.17, №5. — P.719—750.
Saito I., Asano T., Sano K. et al. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage // Neurosurgery. —1998.—V.42,№2.—P.269—278.
Sherman D.G. Heparin and heparinoids in stroke // Neurology.—1998. — V.51, №3, Suppl.3. — P.56—58.
Shishido T., Suzuki R., Qian L. The role of superoxide anions in the pathogenesis of cerebral vasospasm // Stroke.—1994. — V.25, №4. — P.864—868.
Smith S.L., Scherch H.M., Hall E.D. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury // J. Neurosurg.—1996. — V.84,№2. — P.229—233.
Suarez-Rivera O. Acute hydrocephalus after subarachnoid hemorrhage // Surg. Neurol.—1998. — V.49, №5. — P.563—565.
Tsementzis S.A., Meyer C.H., Hitchcock E.R. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid // Neurochirurgia.—1992. — Vol.35, №3. — P.74—78.
Ullman J.S., Bederson J.B. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes // Crit. Care Clin.—1996. — V.12, №3. — P.697—707.
Vermeij F.H., Hasan D., Bijvoet H.W., Avezaat C.J. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage // Stroke.—1998 — V.29, №5. — P.924—930.
Vermeulen M. Subarachnoid haemorrhage: diagnosis and treatment // J. Neurol.—1996. — V.243, №7. — P.496—501.
Vermylen J. Interventions with use of LMWH
// Intеrn. Sympos. on Low Molecular Weighted Heparins and Celated Polysacekarides. — Munchen, 1991. — P.4—5.
Voldby B.O., Enevoldsen E.M., Jensen F.T. Regional CBF, intraventricular pressure and cerebral metabolism in patients with ruptured intracranial aneurysms // J. Neurosurg.—1985. — V.62. — P.48—58.
Wang D.Z., Futrell N., Taylon C., Millikan C. Anticoagulation for prevention of cerebral infarcts following subarachnoid hemorrhage // Surg. Neurol.—1995. — V.44, №3. — P.270—274.
Welty T.E., Horner T.G. Pathophysiology and treatment of subarachnoid hemorrhage // Clin. Pharm.—1990. — №9. — P.35—39.
Woo M.H., Kale-Pradhan P.B. Fludrocortisone in the treatment of subarachnoid hemorrhage-induced hyponatremia // Ann. Pharmacother.—1997. — V.31, №5. — Р.637—639.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2002 L. A. Dzyak, N. O. Zorin, V. A. Golik
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.